疑似肺栓塞的简化诊断管理(YEARS研究):一项前瞻性、多中心、队列研究
该前瞻性多中心队列研究在荷兰12家医院连续纳入3616例疑似肺栓塞患者,最终3465例纳入分析。采用YEARS临床决策规则(深静脉血栓临床征象、咯血、肺栓塞是否为最可能诊断三项)联合D-二聚体:无YEARS条目且D-二聚体<1000 ng/mL,或有≥1个条目且D-二聚体<500 ng/mL者排除肺栓塞,其余行CTPA。排除肺栓塞且未抗凝的2946例患者中,3个月随访症状性静脉血栓栓塞发生率为0.61%(95%CI 0.36-0.96),致死性肺栓塞0.20%(95%CI 0.07-0.44)。YEARS算法使48%患者免于CTPA,较Wells规则联合固定D-二聚体<500 ng/mL阈值(34%)绝对减少14%(95%CI 12-16)。
要点
- YEARS算法三项临床条目:深静脉血栓临床征象、咯血、肺栓塞是否为最可能诊断;联合D-二聚体阈值分层排除肺栓塞。
- 无YEARS条目且D-二聚体<1000 ng/mL,或有≥1个条目且D-二聚体<500 ng/mL时,可考虑排除肺栓塞,无需CTPA。
- 排除肺栓塞且未抗凝的2946例中,3个月症状性静脉血栓栓塞发生率为0.61%(95%CI 0.36-0.96),致死性肺栓塞0.20%(95%CI 0.07-0.44)。
- YEARS算法使48%(1651例)患者免于CTPA,Wells规则联合固定D-二聚体<500 ng/mL阈值仅34%(1174例)免于CTPA,绝对差异14%(95%CI 12-16)。
- YEARS算法在各年龄组及多个相关亚组中均减少CTPA检查,且不增加遗漏静脉血栓栓塞风险。
适用人群与场景
- 荷兰12家医院连续纳入的临床疑似急性肺栓塞患者,年龄不限,纳入时间为2013年10月5日至2015年7月9日。
- 共3616例疑似肺栓塞患者被筛选,151例(4%)被排除,最终3465例纳入分析。
诊断标准与关键阈值
- YEARS临床决策规则包含三项:深静脉血栓临床征象、咯血、肺栓塞是否为最可能诊断。
- 无YEARS条目且D-二聚体<1000 ng/mL,可排除肺栓塞。
- 有≥1个YEARS条目且D-二聚体<500 ng/mL,可排除肺栓塞。
- 不符合上述排除标准者行CTPA。
处置流程与药物剂量
- 第一步:同时评估YEARS临床决策规则三项条目和D-二聚体浓度。
- 第二步:无YEARS条目且D-二聚体<1000 ng/mL,或≥1个YEARS条目且D-二聚体<500 ng/mL,考虑排除肺栓塞,不予抗凝。
- 第三步:其余患者行CTPA以诊断或排除肺栓塞。
研究设计与关键结果
- 研究类型:前瞻性、多中心、队列研究,荷兰12家医院,连续纳入3616例疑似肺栓塞患者,151例(4%)被排除,3465例纳入分析。
- 基线时456例(13%)诊断为肺栓塞;2946例(85%)排除肺栓塞且未抗凝,其中18例在3个月随访期间诊断为症状性静脉血栓栓塞(0.61%,95%CI 0.36-0.96),6例为致死性肺栓塞(0.20%,95%CI 0.07-0.44)。
- YEARS算法下1651例(48%)无CTPA指征,若应用Wells规则联合固定D-二聚体<500 ng/mL阈值则仅1174例(34%)无CTPA指征,绝对差异14%(95%CI 12-16)。
- YEARS算法在各年龄组及多个相关亚组中均减少CTPA检查。
证据类型、等级与局限
- 证据类型:前瞻性、多中心、队列研究(YEARS研究),注册号NTR4193。
- 安全性主要结局采用符合方案分析,效率次要结局采用意向诊断分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对疑似肺栓塞患者,可按照YEARS算法同步评估三项临床条目和D-二聚体,以减少不必要的CTPA检查。
- 无YEARS条目且D-二聚体<1000 ng/mL,或有≥1个条目且D-二聚体<500 ng/mL时,可考虑排除肺栓塞而不行CTPA。
- YEARS算法在全部年龄组及多个相关亚组中均能减少CTPA使用,且3个月静脉血栓栓塞风险低。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Validated diagnostic algorithms in patients with suspected pulmonary embolism are often not used correctly or only benefit subgroups of patients, leading to overuse of computed tomography pulmonary angiography (CTPA). The YEARS clinical decision rule that incorporates differential D-dimer cutoff values at presentation, has been developed to be fast, to be compatible with clinical practice, and to reduce the number of CTPA investigations in all age groups. We aimed to prospectively evaluate this novel and simplified diagnostic algorithm for suspected acute pulmonary embolism.
METHODS: We did a prospective, multicentre, cohort study in 12 hospitals in the Netherlands, including consecutive patients with suspected pulmonary embolism between Oct 5, 2013, to July 9, 2015. Patients were managed by simultaneous assessment of the YEARS clinical decision rule, consisting of three items (clinical signs of deep vein thrombosis, haemoptysis, and whether pulmonary embolism is the most likely diagnosis), and D-dimer concentrations. In patients without YEARS items and D-dimer less than 1000 ng/mL, or in patients with one or more YEARS items and D-dimer less than 500 ng/mL, pulmonary embolism was considered excluded. All other patients had CTPA. The primary outcome was the number of independently adjudicated events of venous thromboembolism during 3 months of follow-up after pulmonary embolism was excluded, and the secondary outcome was the number of required CTPA compared with the Wells' diagnostic algorithm. For the primary outcome regarding the safety of the diagnostic strategy, we used a per-protocol approach. For the secondary outcome regarding the efficiency of the diagnostic strategy, we used an intention-to-diagnose approach. This trial is registered with the Netherlands Trial Registry, number NTR4193.
FINDINGS: 3616 consecutive patients with clinically suspected pulmonary embolism were screened, of whom 151 (4%) were excluded. The remaining 3465 patients were assessed of whom 456 (13%) were diagnosed with pulmonary embolism at baseline. Of the 2946 patients (85%) in whom pulmonary embolism was ruled out at baseline and remained untreated, 18 patients were diagnosed with symptomatic venous thromboembolism during 3-month follow-up (0·61%, 95% CI 0·36-0·96) of whom six had fatal pulmonary embolism (0·20%, 0·07-0·44). CTPA was not indicated in 1651 (48%) patients with the YEARS algorithm compared with 1174 (34%) patients, if Wells' rule and fixed D-dimer threshold of less than 500 ng/mL would have been applied, a difference of 14% (95% CI 12-16).
INTERPRETATION: In our study pulmonary embolism was safely excluded by the YEARS diagnostic algorithm in patients with suspected pulmonary embolism. The main advantage of the YEARS algorithm in our patients is the absolute 14% decrease of CTPA examinations in all ages and across several relevant subgroups.
FUNDING: This study was supported by unrestricted grants from the participating hospitals.
参考来源
- van der Hulle T, Cheung WY, Kooij S, et al. Simplified diagnostic management of suspected pulmonary embolism (the YEARS study): a prospective, multicentre, cohort study. Lancet. 2017. PMID: 28549662. doi:10.1016/S0140-6736(17)30885-1
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。